Arch Therapeutics Management
Management criteria checks 2/4
Arch Therapeutics' CEO is Terrence Norchi, appointed in Jan 2006, has a tenure of 18.83 years. total yearly compensation is $491.00K, comprised of 91.8% salary and 8.2% bonuses, including company stock and options. directly owns 0.34% of the company’s shares, worth $3.00K. The average tenure of the management team and the board of directors is 3.5 years and 1.8 years respectively.
Key information
Terrence Norchi
Chief executive officer
US$491.0k
Total compensation
| CEO salary percentage | 91.8% |
| CEO tenure | 18.8yrs |
| CEO ownership | 0.3% |
| Management average tenure | 3.5yrs |
| Board average tenure | 1.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$13m |
| Mar 31 2024 | n/a | n/a | -US$8m |
| Dec 31 2023 | n/a | n/a | -US$8m |
| Sep 30 2023 | US$491k | US$451k | -US$7m |
| Jun 30 2023 | n/a | n/a | -US$6m |
| Mar 31 2023 | n/a | n/a | -US$6m |
| Dec 31 2022 | n/a | n/a | -US$6m |
| Sep 30 2022 | US$451k | US$451k | -US$5m |
| Jun 30 2022 | n/a | n/a | -US$5m |
| Mar 31 2022 | n/a | n/a | -US$6m |
| Dec 31 2021 | n/a | n/a | -US$7m |
| Sep 30 2021 | US$635k | US$451k | -US$6m |
| Jun 30 2021 | n/a | n/a | -US$6m |
| Mar 31 2021 | n/a | n/a | -US$5m |
| Dec 31 2020 | n/a | n/a | -US$4m |
| Sep 30 2020 | US$698k | US$438k | -US$5m |
| Jun 30 2020 | n/a | n/a | -US$4m |
| Mar 31 2020 | n/a | n/a | -US$5m |
| Dec 31 2019 | n/a | n/a | -US$4m |
| Sep 30 2019 | US$429k | US$429k | -US$5m |
| Jun 30 2019 | n/a | n/a | -US$5m |
| Mar 31 2019 | n/a | n/a | -US$6m |
| Dec 31 2018 | n/a | n/a | -US$8m |
| Sep 30 2018 | US$829k | US$425k | -US$5m |
Compensation vs Market: Terrence's total compensation ($USD491.00K) is about average for companies of similar size in the US market ($USD652.28K).
Compensation vs Earnings: Terrence's compensation has increased whilst the company is unprofitable.
CEO
Terrence Norchi (59 yo)
18.8yrs
Tenure
US$491,000
Compensation
Dr. Terrence W. Norchi, M.D., serves as Chairman of the Board at Arch Therapeutics, Inc. since July 19, 2018. He is the Co-Founder of Arch Therapeutics, Inc. and has been its Chief Executive Officer and Pr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 18.8yrs | US$491.00k | 0.34% $ 3.0k | |
| CFO & Treasurer | 3.5yrs | US$354.16k | 0.22% $ 2.0k | |
| Co-Founder & Scientific Advisor | no data | no data | no data | |
| Vice President of Sales | less than a year | no data | no data |
3.5yrs
Average Tenure
Experienced Management: ARTH's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 11.6yrs | US$491.00k | 0.34% $ 3.0k | |
| Independent Director | 2.9yrs | US$8.10k | 0% $ 0 | |
| Member of Medical Advisory Board | 1.8yrs | no data | no data | |
| Member of Medical Advisory Board | 1.8yrs | no data | no data | |
| Member of Medical Advisory Board | 1.8yrs | no data | no data | |
| Member of Medical Advisory Board | 1.8yrs | no data | no data | |
| Member of Medical Advisory Board | 1.8yrs | no data | no data | |
| Clinical Advisor | no data | no data | no data |
1.8yrs
Average Tenure
64yo
Average Age
Experienced Board: ARTH's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.